COBO-Q Newsletter - Quality Control Genome Editing (Breaking July 2019) - Cobo Technologies
 
 
 
 
 
 
 
 

Breaking News

 
 
 
 
 

CRISPR Researchers to Benefit from COBO Technologies and SCIEX Partnership

PRESS RELEASE

We are excited to announce our new partnership with SCIEX for our proteomic expression analysis platform, PIPPR powered by SWATH LC-MS.

"A co-marketing agreement between the two companies will offer PIPPR, a unique protein expression analysis platform, developed for CRISPR applications and powered by SWATH® Acquisition. PIPPR is uniquely and specifically designed to help CRISPR researchers"

Read more...CRISPR Researchers to Benefit from COBO Technologies and SCIEX Partnership
https://www.businesswire.com/news/home/20190704005313/en/CRISPR-Researchers-Benefit-COBO-Technologies-SCIEX-Partnership
 
 
 
 
 

We will be happy to hear from you

Interested in more info about our services or products within QC Genome Editing. Please use this contact form or send email directly to: info@cobotechnologies.com.

Contact
 
 
 
linkedin